In open-label phase: treatment with tofacitinib ( DrugBank: Tofacitinib )

1 disease

ID	Disease name (Link within this page)	Number of trials
107	Juvenile idiopathic arthritis	1

107. Juvenile idiopathic arthritis

Clinical trials : 447 / Drugs : 297 - (DrugBank : 57) / Drug target genes : 52 - Drug target pathways : 146

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03000439 (ClinicalTrials.gov)	May 10, 2018	9/11/2016	A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA	EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENIL ...	Arthritis Juvenile Idiopathic	Drug: In open-label phase: treatment with tofacitinib;Drug: In double-blind phase: treatment with to ...	Pfizer	NULL	Recruiting	2 Years	17 Years	All	100	Phase 3	United States;Argentina;Belgium;Brazil;Canada;China;Costa Rica;Germany;Hungary;India;Israel;Italy;Me ...

First Previous1Next Last